Evidence map›Paper›PMID 39803044›Full record

ArticleCureus2024

Approaches and Challenges in Managing Treatment-Resistant Hypertension: A Case Report.

Julian Morano, Samer Kholoki

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Julian MoranoInternal Medicine, Saint James School of Medicine, The Valley, AIA.
Samer KholokiInternal Medicine, University of Chicago Medicine AdventHealth La Grange, Chicago, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatment-resistant hypertension (TRH) is defined by consistently elevated blood pressure readings unresponsive to medical management. In clinical practice, it poses a significant challenge due to the intertwining variables that may cause the issue to persist such as lifestyle, genetics, and other comorbidities, as opposed to simple medication non-adherence. This report describes the case of a 68-year-old female patient presenting for a routine follow-up with persistently elevated ambulatory blood pressure readings. The patient was compliant with her medication regimen and followed lifestyle modification guidelines. Physical exam and review of systems showed no changes relative to previous visits. Laboratory findings were insignificant other than a low estimated glomerular filtration rate (eGFr) of 52. The patient's condition was stable but required further management to bring blood pressure readings into or closer to optimal range. This case looks at how the patient was managed and the rationale behind these decisions based on the patient's clinical history. It also emphasizes the importance of regular monitoring and constant adjustment of medical management to treatment for patients with TRH due to its unrelenting nature.

Indexed as

blood pressure managementmedical comorbiditiespolypharmacyrenal fibromuscular dysplasiatreatment-resistant hypertension

Identifiers

PMID39803044
PMCPMC11723567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.